Log in to save to my catalogue

The combination of artesunate and carboplatin exerts a synergistic anti‐tumour effect on non‐small c...

The combination of artesunate and carboplatin exerts a synergistic anti‐tumour effect on non‐small c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2358581007

The combination of artesunate and carboplatin exerts a synergistic anti‐tumour effect on non‐small cell lung cancer

About this item

Full title

The combination of artesunate and carboplatin exerts a synergistic anti‐tumour effect on non‐small cell lung cancer

Publisher

Australia: Wiley Subscription Services, Inc

Journal title

Clinical and experimental pharmacology & physiology, 2020-06, Vol.47 (6), p.1083-1091

Language

English

Formats

Publication information

Publisher

Australia: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

Carboplatin (CBP) is a widely used targeted anticancer therapeutic drug; however, multi‐drug resistance induced by the accumulation of CBP eventually causes diseases progression. The anti‐malarial drug artesunate (ART) also exerts anticancer effects in various cancers; however, the combined effect of ART and CBP on non‐small cell lung cancer (NSCLC...

Alternative Titles

Full title

The combination of artesunate and carboplatin exerts a synergistic anti‐tumour effect on non‐small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2358581007

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2358581007

Other Identifiers

ISSN

0305-1870

E-ISSN

1440-1681

DOI

10.1111/1440-1681.13287

How to access this item